|
CCMV Gag-(7-25)
|
|
|
|
P1, Human
|
|
|
|
TAT-HA2 Fusion Peptide
|
|
|
|
TAT-NSF700scr
|
|
|
|
NGR Peptide 3
|
|
|
|
NGR Peptide 2
|
|
|
|
Boc-(S)-alpha-(2-chloro-benzyl)-proline
|
|
706806-67-9
|
|
2-Pyridinol-1-Oxide
|
|
13161-30-3
|
|
N-t-Butoxycarbonyl-trans-4-(3-pyridinylmethyl)-L-proline;(2S,4R)-1-t-Butoxycarbonyl-4-(3-pyridylmethyl)pyrrolidine-2-carboxylic acid
|
|
959580-99-5
|
|
L-Tyrosine
|
|
60-18-4
|
|
(D-Arg)9
|
|
|
|
SV-40 Large T-antigen Nuclear Localization Signal (NLS)
|
|
|
|
TAT-GluR23A Fusion Peptide
|
|
|
|
TfR Targeting Peptide
|
|
|
|
N-α-t-Butoxycarbonyl-(R)-α-(2-Pyridilmethyl)-proline
|
|
959576-41-1
|
|
MPS-Gαi3
|
|
|
|
HTLV-II Rex-(4-16)
|
|
|
|
TAT P59W
|
|
|
|
N-t-Butoxycarbonyl-trans-4-(2-pyridinylmethyl)-L-proline
|
|
959581-97-6
|
|
Methyl L-pyroglutamate
|
|
4931-66-2
|
|
TAT (47-57) GGG-Cys(Npys)
|
|
|
|
Technetium tc 99m Apcitide
|
|
178959-14-3
|
|
N-t-Butoxycarbonyl-(S)-γ-(2-Furanylmethyl)-L-proline
|
|
959583-73-4
|
|
P22 N (14-30)
|
|
|
|
P-beta
|
|
|
|
TAT-NSF81scr Fusion Polypeptide, scrambled
|
|
|
|
Triphenylmethanol
|
|
76-84-6
|
|
N-t-Butoxycarbonyl-(S)-α-(4-Pyridylmethyl)-proline
|
|
1217722-02-5
|
|
L-Valine
|
|
72-18-4
|
|
Pep-1 uncapped
|
|
395069-86-0
|
|
L(+)-Ornithine hydrochloride
|
|
3184-13-2
|
|
Membrane-Permeable Sequence, MPS
|
|
|
|
Cell Penetrating ARF Peptide (26-44)
|
|
|
|
NRTN (Neurturin), Human
|
|
|
|
pVEC (Cadherin-5)
|
|
|
|
TAT-NSF222scr Fusion Polypeptide, scrambled
|
|
|
|
Novexatin
|
|
942577-31-3
|
|
L-alanine
|
|
56-41-7
|
|
L-Glutamic acid
|
|
56-86-0
|
|
L(+)-Asparagine monohydrate
|
|
5794-13-8
|
|
L-lysine
|
|
56-87-1
|
|
BMV Gag-(7-25)
|
|
|
|
Pep-7
|
|
|
|
Tat-Beclin-1, scrambled
|
|
|
|
VP-22
|
|
|
|
Glycine
|
|
56-40-6
|
|
L-Threonine
|
|
72-19-5
|
|
N-t-Butoxycarbonyl-(S)-α-(3-Thiophenylmethyl)-proline
|
|
1217714-91-4
|
|
Cys(Npys)-(Arg)9
|
|
1417221-06-7
|
|
[Cys58]105Y, α1-antitrypsin (358-374)
|
|
|
|
Ethyl cyanoglyoxylate-2-oxime
|
|
3849-21-6
|
|
L-Glutamine
|
|
56-85-9
|
|
CADY
|
|
|
|
D-TAT (47-57)
|
|
|
|
HIV-1 TAT (48-60)
|
|
|
|
Pen2W2F
|
|
|
|
TAT-NSF222 Fusion Peptide
|
|
|
|
L-Cystine
|
|
56-89-3
|
|
L-Citrulline
|
|
372-75-8
|
|
PAC-113
|
|
|
|
TAT (47-57), FAM-labeled
|
|
1676104-81-6
|
|
L-Cysteine Hydrochloride
|
|
52-89-1
|
|
L-Histidine
|
|
71-00-1
|
|
Pep-1-Cysteamine
|
|
863608-35-9
|
|
Solanezumab
|
|
955085-14-0
|
|
N-(t-Butoxycarbonyl)hydroxylamine
|
|
36016-38-3
|
|
Cys-TAT (48-60)
|
|
|
|
Hel 13-5
|
|
177942-21-1
|
|
TAT-GluR23Y, scrambled
|
|
|
|
TAT-NSF700 Fusion Peptide
|
|
|
|
Cys(Npys)-TAT (47-57)
|
|
|
|
Boc-(R)-alpha-(4-Pyridinylmethyl)-proline
|
|
959576-40-0
|
|
N-α-t-Butoxycarbonyl-(S)-α-(2-Pyridilmethyl)proline
|
|
1217765-55-3
|
|
Cys(Npys)-TAT (47-57), FAM-labeled
|
|
|
|
FITC-beta-Ala-NYAD-1 (NYAD-2)
|
|
|
|
Tat-Beclin-1
|
|
|
|
SynB1 (1-18)
|
|
|
|
N-t-Butoxycarbonyl-(S)-α-(2-furanylmethyl)-proline
|
|
1217622-28-0
|
|
Cereolysin
|
|
72270-31-6
|
|
Nuclear Localiation Signal Peptide
|
|
|
|
NYAD-1
|
|
|
|
D-Alanine
|
|
338-69-2
|
|
CAD-2
|
|
|
|
FITC-LC-Antennapedia (43-58) Peptide
|
|
|
|
2: PN: US20040072744 SEQID: 2 claimed protein
|
|
389572-87-6
|
|
MEK1 Derived Peptide Inhibitor 1
|
|
|
|
L-Leucine
|
|
61-90-5
|
|
MPGΔNLS, HIV related
|
|
|
|
N-t-Butoxycarbonyl-(S)-α-(2-Thiophenylmethyl)-proline
|
|
1217823-56-7
|
|
L-Pyroglutamic acid
|
|
98-79-3
|
|
L-methionine
|
|
63-68-3
|
|
Thymus peptide C
|
|
316791-23-8
|
|
(Arg)9 biotin labeled
|
|
|
|
Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R)
|
|
|
|
D-(-)-2-Phenylglycine
|
|
875-74-1
|
|
Peptide C105Y
|
|
247572-63-0
|
|
Bivalirudin
|
|
128270-60-0
|
|
Antennapedia Peptide (TFA)
|
|
|
|
Dimethyl-pyridin-4-yl-amine (DMAP)
|
|
1122-58-3
|
|
TAT-C (48-57)
|
|
627079-23-6
|